197 related articles for article (PubMed ID: 29681462)
21. Age-group differences in human papillomavirus types and cofactors for cervical intraepithelial neoplasia 3 among women referred to colposcopy.
Gargano JW; Nisenbaum R; Lee DR; Ruffin MT; Steinau M; Horowitz IR; Flowers LC; Tadros TS; Birdsong G; Unger ER
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):111-21. PubMed ID: 22028398
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of high-risk human papillomavirus genotyping for cervical cancer screening. A multicentre screening cohort study in rural China.
Yu YQ; Jiang MY; Zhang X; Pan QJ; Dang L; Feng RM; Ali NM; Chen W; Qiao YL
An Sist Sanit Navar; 2024 May; 47(2):. PubMed ID: 38817086
[TBL] [Abstract][Full Text] [Related]
23. Calendar-period trends in cervical precancer and cancer diagnoses since the introduction of human papillomavirus and cytology co-testing into routine cervical cancer screening at Kaiser Permanente Northern California.
Befano B; Wentzensen N; Lorey T; Poitras N; Cheung LC; Schiffman M; Clarke MA; Cohen C; Kinney W; Locke A; Castle PE
Gynecol Oncol; 2024 May; 184():89-95. PubMed ID: 38301311
[TBL] [Abstract][Full Text] [Related]
24. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.
Katki HA; Kinney WK; Fetterman B; Lorey T; Poitras NE; Cheung L; Demuth F; Schiffman M; Wacholder S; Castle PE
Lancet Oncol; 2011 Jul; 12(7):663-72. PubMed ID: 21684207
[TBL] [Abstract][Full Text] [Related]
25. Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland.
Leinonen MK; Anttila A; Malila N; Dillner J; Forslund O; Nieminen P
Br J Cancer; 2013 Nov; 109(11):2941-50. PubMed ID: 24136148
[TBL] [Abstract][Full Text] [Related]
26. Impact of HPV vaccination on outcome of cervical cytology screening in Denmark-A register-based cohort study.
Thamsborg LH; Napolitano G; Larsen LG; Lynge E
Int J Cancer; 2018 Oct; 143(7):1662-1670. PubMed ID: 29707775
[TBL] [Abstract][Full Text] [Related]
27. Clinical use of the Onclarity test with extended HPV genotyping and phenotyping in patients with suspected squamous intraepithelial lesions.
Pruski D; Millert-Kalinska S; Klemenska P; Jach R; Przybylski M
Ginekol Pol; 2024; 95(5):328-334. PubMed ID: 38099664
[TBL] [Abstract][Full Text] [Related]
28. HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial.
Glinska P; Komerska K; Janik B; Olkowicz J; Jedrzejewska I; Macios A; Wieszczy P; Kaminski MF; Arbyn M; Nowakowski A
BMC Cancer; 2023 Nov; 23(1):1118. PubMed ID: 37978452
[TBL] [Abstract][Full Text] [Related]
29. A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus-positive and -Negative Cervical Precancers.
Castle PE; Pierz AJ; Adcock R; Aslam S; Basu PS; Belinson JL; Cuzick J; El-Zein M; Ferreccio C; Firnhaber C; Franco EL; Gravitt PE; Isidean SD; Lin J; Mahmud SM; Monsonego J; Muwonge R; Ratnam S; Safaeian M; Schiffman M; Smith JS; Swarts A; Wright TC; Van De Wyngard V; Xi LF
Cancer Prev Res (Phila); 2020 Oct; 13(10):829-840. PubMed ID: 32655005
[TBL] [Abstract][Full Text] [Related]
30. The relationship of human papillomavirus and cytology co-testing results with endometrial and ovarian cancer diagnoses.
Castle PE; Locke A; Tergas AI; Befano B; Poitras N; Shah NR; Schiffman M; Wentzensen N; Strickler HD; Clarke MA; Lorey T
Gynecol Oncol; 2021 Apr; 161(1):297-303. PubMed ID: 33454132
[TBL] [Abstract][Full Text] [Related]
31. Selecting human papillomavirus genotypes to optimize the performance of screening tests among South African women.
Johnson LG; Saidu R; Mbulawa Z; Williamson AL; Boa R; Tergas A; Moodley J; Persing D; Campbell S; Tsai WY; Wright TC; Denny L; Kuhn L
Cancer Med; 2020 Sep; 9(18):6813-6824. PubMed ID: 32706163
[TBL] [Abstract][Full Text] [Related]
32. Accuracy of Messenger RNA Human Papillomavirus Tests for Diagnostic Triage of Minor Cytological Cervical Lesions: A Systematic Review and Meta-Analysis.
Macedo ACL; Bavaresco DV; Gonçalves JCN; Grande AJ; da Rosa MI
Sex Transm Dis; 2019 May; 46(5):297-303. PubMed ID: 30985633
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of HPV-DNA testing for precancerous cervical lesions.
Moarcăs M; Georgescu IC; Brătilă E; Badea M; Cîrstoiu M
J Med Life; 2014; 7 Spec No. 3(Spec Iss 3):37-9. PubMed ID: 25870692
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of non 16/18 high risk human papilloma virus as a quality metric in gynecological cytology.
Aly FZ; Irhayyim A; Jordan R; Mukhtar F; Klein R
Diagn Cytopathol; 2024 Jul; 52(7):377-380. PubMed ID: 38651180
[TBL] [Abstract][Full Text] [Related]
35. Prospective One Year Follow Up of HIV Infected Women Screened for Cervical Cancer Using Visual Inspection with Acetic Acid, Cytology and Human Papillomavirus Testing in Johannesburg South Africa.
Firnhaber C; Goeieman B; Faesen M; Levin S; Williams S; Rameotshela S; Swarts A; Michelow P; Omar T; Williamson AL; Allan B; Schnippel K; Smith JS
PLoS One; 2016; 11(1):e0144905. PubMed ID: 26730710
[TBL] [Abstract][Full Text] [Related]
36. Correlation of immediate prevalence of cervical precancers and cancers with HPV genotype and age in women with ASC-US/hrHPV+: a retrospective analysis of 2292 cases.
Liu Q; Zhang T; Chen L; Zhou X; Zhang X; Zheng W; Niu S; Zhou F
J Clin Pathol; 2024 Apr; 77(5):338-342. PubMed ID: 36653168
[TBL] [Abstract][Full Text] [Related]
37. Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3.
Rodríguez AC; Schiffman M; Herrero R; Hildesheim A; Bratti C; Sherman ME; Solomon D; Guillén D; Alfaro M; Morales J; Hutchinson M; Cheung L; Wacholder S; Burk RD
Int J Cancer; 2012 Oct; 131(8):1874-81. PubMed ID: 22213126
[TBL] [Abstract][Full Text] [Related]
38. Home Self-Collection by Mail to Test for Human Papillomavirus and Sexually Transmitted Infections.
Des Marais AC; Zhao Y; Hobbs MM; Sivaraman V; Barclay L; Brewer NT; Smith JS
Obstet Gynecol; 2018 Dec; 132(6):1412-1420. PubMed ID: 30399091
[TBL] [Abstract][Full Text] [Related]
39. Five-year risk of CIN3 after short-term HPV-DNA negativity in cytology-negative women: a population-based cohort study.
Del Mistro A; Giorgi Rossi P; Frayle H; Pasquale L; Campari C; Ronco G; Zorzi M
BJOG; 2019 Oct; 126(11):1365-1371. PubMed ID: 31356722
[TBL] [Abstract][Full Text] [Related]
40. Testing for viral DNA integration among HPV-positive women to detect cervical precancer: An observational cohort study.
Hu T; Li K; He L; Huang F; Yang F; Chen S; Wang H; Ma D; Huang X; Wu P
BJOG; 2024 Feb; 131(3):309-318. PubMed ID: 37408516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
